XOMA to Present at Upcoming Investor Conferences
February 18 2015 - 12:36PM
XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and
development of therapeutic antibodies, announced today members of
its management team are scheduled to present at three upcoming
investor conferences. The details are as follows:
- RBC Capital Markets Global Healthcare Conference on Tuesday,
February 24, 2015, at 8:00 a.m. ET
- Cowen and Company 35th Annual Health Care Conference on
Wednesday, March 4, 2015, at 10:40 a.m. ET
- 27th Annual ROTH Conference on Monday, March 9, 2015, at 12:00
p.m. PT
Live audio webcasts of the presentations can be accessed through
the Investors and Media section of XOMA's website at
http://investors.xoma.com/events.cfm. Archived versions of the
webcast will be available via replay for 60 days following the
presentation.
About XOMA Corporation
XOMA's innovative product candidates are the result of the
Company's expertise in developing ground-breaking monoclonal
antibodies, including allosteric modulating antibodies, which has
created opportunities to develop new classes of therapeutic
antibodies with the potential to treat a wide range of human
diseases. XOMA is developing its lead product gevokizumab (IL-1
beta modulating antibody) with SERVIER through a global Phase 3
program for Behçet's disease uveitis and non-infectious uveitis and
in a Phase 3 program in pyoderma gangrenosum, as well as ongoing
proof-of-concept studies in other IL-1-mediated diseases. XOMA's
scientific research has also produced the XMet program, which
consists of three classes of Selective Insulin Receptor Modulators
(SIRMs) antibodies, including XOMA 358, that are being investigated
for the treatment of abnormal metabolic states. XOMA's extensive
antibody expertise includes antibody discovery, optimization, cell
line and process development.
More detailed information can be found at www.xoma.com.
CONTACT: Company and Investor Contacts:
Ashleigh Barreto
510-204-7482
barreto@xoma.com
Juliane Snowden
The Oratorium Group, LLC
jsnowden@oratoriumgroup.com
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Mar 2024 to Apr 2024
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Apr 2023 to Apr 2024